Advanced search
Publication Cover
Current Medical Research and Opinion Volume 34, 2018 - Issue 4: Neurotherapeutics & Pain
Submit an article Journal homepage
228
Views
5
CrossRef citations to date
0
Altmetric
Rheumatology

Evaluation of healthcare costs and utilization for patients with gout: a population-based matched cohort study

Yi-Yun LeeDepartment of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan; ;Department of Pharmacy, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan; ORCID Iconhttp://orcid.org/0000-0002-8439-4291
ORCID Icon,
Chao-Hsiun TangSchool of Health Care Administration, College of Management, Taipei Medical University, Taipei City, Taiwan;
,
Jin-Hua ChenBiostatistics Center/Masters Program in Big Data Technology and Management, College of Management, Taipei Medical University, Taipei City, Taiwan;
,
Li-Na KuoDepartment of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan; ;Department of Pharmacy, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan;
&
Yu KoDepartment of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan; ;Research Center of Pharmacoeconomics, College of Pharmacy, Taipei Medical University, Taipei, TaiwanCorrespondence[email protected]
Pages 735-740 | Received 22 Aug 2017, Accepted 13 Dec 2017, Published online: 16 Jan 2018

References

  • Majdan M, Borys O. Gout and comorbidities associated with hyperuricemia. Ann Acad Med Stetin 2010;56:34-9
  • Karis E, Crittenden DB, Pillinger MH. Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way street. South Med J 2014;107:235-41
  • Wertheimer A, Morlock R, Becker MA. A revised estimate of the burden of illness of gout. Curr Ther Res Clin Exp 2013;75:1-4
  • Brook RA, Forsythe A, Smeeding JE, et al. Chronic gout: epidemiology, disease progression, treatment and disease burden. Curr Med Res Opin 2010;26:2813-21
  • Kuo CF, Grainge MJ, See LC, et al. Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis Res Ther 2015;17:13
  • Kim KY, Ralph Schumacher H, Hunsche E, et al. A literature review of the epidemiology and treatment of acute gout. Clin Ther 2003;25:1593-617
  • Jackson R, Shiozawa A, Buysman EK, et al. Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis. BMJ Open 2015;5:e007214
  • Wu EQ, Patel PA, Yu AP, et al. Disease-related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm 2008;14:164-75
  • Fischer A, Cloutier M, Goodfield J, et al. The direct economic burden of gout in an elderly Canadian population. J Rheumatol 2017;44:95-101
  • Brook RA, Kleinman NL, Patel PA, et al. The economic burden of gout on an employed population. Curr Med Res Opin 2006;22:1381-9
  • Chi MJ, Lee CY, Wu SC. The prevalence of chronic conditions and medical expenditures of the elderly by chronic condition indicator (CCI). Arch Gerontol Geriatr 2011;52:284-9
  • Xu FJ. Analysis of gout patients’ health services utilization. China Medical University, Masters thesis, 2003
  • nhird.nhri.org.tw[Internet]. Taiwan: Center for Biomedical Resources of NHRI; [cited 2017 Jun 9]. Available from: https://nhird.nhri.org.tw/en/index.html.
  • Wu EQ, Forsythe A, Guérin A, et al. Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy. Am J Ther 2012;19:e157-66
  • Saseen JJ, Agashivala N, Allen RR, et al. Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks. Rheumatology (Oxford) 2012;51:2004-12
  • Kuo CF, Grainge MJ, Mallen C, et al. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis 2015;74:661-7
  • Singh JA. Racial and gender disparities among patients with gout. Curr Rheumatol Rep 2013;15:307
  • Kuo CF, Grainge MJ, Zhang W, et al. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 2015;11:649-62
  • Park H, Rascati KL, Prasla K, et al. Evaluation of health care costs and utilization patterns for patients with gout. Clin Ther 2012;34:640-52
  • Singh JA, Sarkin A, Shieh M, et al. Health care utilization in patients with gout. Semin Arthritis Rheum 2011;40:501-11
  • Lynch W, Chan W, Kleinman N, et al. Economic burden of gouty arthritis attacks for employees with frequent and infrequent attacks. Popul Health Manag 2013;16:138-45
  • Spaetgens B, Wijnands JM, van Durme C, et al. Cost of illness and determinants of costs among patients with gout. J Rheumatol 2015;42:335-44

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.